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General. All reactions were carried out in flame-dried glassware under Ar. The solvents were 
purified by distillation over the drying agents indicated and were transferred under Ar: THF, 
Et2O (Mg-anthracene), CH2Cl2 (P4O10), MeCN, Et3N (CaH2), MeOH (Mg), DMF, DMA 
(Desmodur®, dibutyltin dilaurate), hexane, toluene (Na/K). Flash chromatography: Merck 
silica gel 60 (230-400 mesh). NMR: Spectra were recorded on a Bruker DPX 300, AV 400, or 
DMX 600 spectrometer in the solvents indicated; chemical shifts (δ) are given in ppm relative 
to TMS, coupling constants (J) in Hz. The solvent signals were used as references and the 
chemical shifts converted to the TMS scale (CDCl3: δC ≡ 77.0 ppm; residual CHCl3 in CDCl3: 
δH ≡ 7.24 ppm; CD2Cl2: δC ≡ 53.8 ppm; residual CH2Cl2 in CD2Cl2: δH ≡ 5.32 ppm). IR: 
Nicolet FT-7199 spectrometer, wavenumbers (ν~ ) in cm−1. MS (EI): Finnigan MAT 8200 (70 
eV), ESI-MS: Finnigan MAT 95, accurate mass determinations: Bruker APEX III FT-MS (7 
T magnet). Melting points: Büchi melting point apparatus B-540 (corrected). Elemental 
analyses: H. Kolbe, Mülheim/Ruhr. All commercially available compounds (Fluka, Lancaster, 



























5-(3-Bromo-propylsulfanyl)-1-tert-butyl-1H-tetrazole. DEAD (1.73 mL, 11 mmol) was 
added to a solution of PPh3 (2.89 g, 11 mmol) and 1-tert-butyl-1,4-dihydrotetrazole-5-thione 
(1.74 g, 11 mmol) in THF. The mixture was cooled to 0°C before 3-bromopropan-1-ol (0.9 
mL, 10 mmol) was added via syringe. The resulting solution was stirred at ambient 
temperature for 30 min before all volatile materials were evaporated. The residue was purified 
by flash chromatography (hexanes/EtOAc gradient, 30/1→20/1→15/1→10/1) to give the title 
compound as a white solid (2.32 g, 83%). m.p.: 50-53°C. IR (film) 2982, 2938, 1507, 1473, 
1431, 1409, 1375, 651, 544 cm-1. 1H NMR (CDCl3, 300 MHz): δ = 3.54 (4H, q, J = 6.5 Hz), 
2.42 (2H, quint., J = 6.7 Hz), 1.73 (9H, s). 13C NMR (CDCl3, 75 MHz): δ = 152.2, 61.3, 32.2, 
31.8, 31.7, 28.9 (3C). Anal. calcd for C8H15BrN4S: C 34.42, H 5.42, N 20.07, found: C 34.74, 
H 5.52, N 20.14. 
1-tert-Butyl-5-cyclopropanesulfonyl-1H-tetrazole. A solution of Mo7O24(NH4)6.xH2O (2.1 
g, 1.7 mmol) in H2O2 (30 % w/w, 21 mL) was added dropwise at 0°C within 5 minutes to a 
solution of 5-(3-bromo-propylsulfanyl)-1-tert-butyl-1H-tetrazole (5.54 g, 20.2 mmol) in EtOH 
(155 mL). After stirring for 90 min at room temperature, the solvent was evaporated. The 
crude material was dissolved in  tert-butyl methyl ether, the organic phase was washed with 
water and brine, dried over Na2SO4 and concentrated.  
A solution of the resulting colorless oil (5.77 g) in THF (45 mL) was slowly added via a 
dropping funnel within 9h to a solution of NaHMDS (3.74 g) in THF (900 mL) at –78°C. 
After the addition was complete, the reacton mixture was stirred for 1 h before it was 
quenched with sat. aq. NH4Cl. The mixture was partitioned between water and tert-butyl 
methyl ether, the combined organic layers were washed with brine, dried over Na2SO4 and 
concentrated. Purification of the residue by flash chromatography (hexanes/EtOAc, 10/1) 
furnished compound 2 as a white solid (3.76 g, 80%). m.p. 93-95 °C. IR (KBr): 3067, 3000, 
1336, 1161, 1052, 877, 709, 615 cm−1. 1H NMR (300 MHz, CDCl3): δ = 3.33-3.23 (1H, m), 
1.86 (9H, s), 1.55-1-46 (2H, m), 1.46-1.33 (2H, m). 13C NMR (75 MHz, CDCl3): δ = 154.9, 
65.5, 33.5, 29.9 (3C), 7.1 (2C). MS (EI) m/z (rel. intensity): 111 (13), 110 (30), 82 (6), 67 (5), 
57 (100), 41 (66). HRMS (ESIpos): calcd for C8H14N4NaO2S: 253.072966, found 
 S-3
253.072974. Anal. calcd for C8H14N4O2S: C 41.73, H 6.13, N 24.33; found C 41.81, H 6.25, 
N 24.42. 
 
2-Allyloxy-3-methoxy-benzaldehyde. 2-Hydroxy-3-methoxy-benzaldehyde (760 mg, 5 
mmol) was added as a solid to a stirred suspension of NaH (150 mg, 6.25 
mmol) in DMF (5 mL) at 0°C. After stirring at room temperature for 2 h, 
allyliodide (0.9 mL, 10 mmol) was introduced and stirring was continued 
for 20 h. For work up, the mixture was diluted with  tert-butyl methyl 
ether and washed with sat. aq. NH4Cl and brine. Drying of the organic 
layer over Na2SO4, evaporation of the solvent, and purification of the residue by flash 
chromatography (hexanes/EtOAc, 15/1) gave the title compound as a pale yellow oil (737 mg, 
68%). IR (neat): 3082, 3011, 2940, 2862, 2841, 2757, 1692, 1648, 1595, 1584, 1482, 1458, 
1442, 1422, 1390, 1267, 1249, 1067, 983, 911, 786 cm−1. 1H NMR (300 MHz, CDCl3): δ = 
10.46 (1H, s), 7.45-7.41 (1H, m), 7.16-7.14 (2H, m), 6.09 (1H, ddt, J = 17.2, 10.4, 5.8 Hz), 
5.35 (1H, dq, J = 17.1, 1.6 Hz), 5.28 (1H, dq, J = 10.4, 1.2 Hz), 4.68 (2H), 3.92 (3H, s). 13C 
NMR (75 MHz, CDCl3): δ = 190.7, 153.2, 151.4, 133.3, 130.3, 124.4, 119.2, 119.1, 118.2, 
75.4, 56.2. MS (EI) m/z (rel. intensity): 192 (57), 151 (100), 136 (23), 131 (11), 122 (25), 108 
(34), 93 (28), 65 (20), 52 (19), 41 (40). HRMS (EI): calcd for C11H12O3: 192.078642, found 
192.078848. Anal. calcd for C11H12O3: C 53.55, H 4.87; found C 53.51, H 4.94. 
 
Preparation of Alkylidenecyclopropanes  
by a Modified Julia-Kocienski Olefination 
 
Representative procedure: 4-Cyclopropylidenemethyl-biphenyl (3). Cs2CO3 (1.95 g, 6 
mmol) was added to a solution of 4-phenyl-benzaldehyde (364 mg, 2 
mmol) and sulfone 2(690 mg, 3 mmol) in THF (15 mL) and DMF (5 
mL). The resulting suspension was stirred at 70°C for 40h. For work 
up, the mixture was poured into a saturated solution of NH4Cl, the 
aqueous layer was extracted with  tert-butyl methyl ether, the combined organic layers were 
washed with brine, dried over Na2SO4, filtered and evaporated. Purification of the residue by 
flash chromatography furnished product 3 as a white solid (313 mg, 76%). m.p. 66-68 °C. IR 
(KBr): 3086, 3033, 2971, 1747, 1596, 1580, 1558, 1521, 1488, 1450, 1427, 1408, 847, 757, 
691 cm−1. 1H NMR (300 MHz, CDCl3): δ = 7.65-7.58 (6H, m), 7.46 (2H, t, J = 7.6 Hz), 7.38-
7.33 (1H, m), 6.82-6.80 (1H, m), 1.51-1.46 (2H, m), 1.26-1.21 (2H, m). 13C NMR (75 MHz, 
CDCl3): δ = 141.0, 139.6, 137.5, 128.9 (2C), 127.3 (2C), 127.2, 127.1 (2C), 127.0 (2C), 
124.8, 118.0, 4.4, 0.9. MS (EI) m/z (rel. intensity): 206 (100), 191 (55), 165 (23), 152 (12), 





deuterated compound 3-D was obtained analogously. 1H NMR (300 MHz, CDCl3): δ = 7.68-
7.56 (6H, m), 7.46 (2H, t, J = 7.6 Hz), 7.40-7.33 (1H, m), 1.48 (2H, dd, J = 10.1, 5.3 Hz), 
1.24 (2H, dd, J = 9.7, 5.7 Hz). 13C NMR (75 MHz, CDCl3): δ = 141.1, 139.6, 137.4, 128.9 
(2C), 127.3 (2C), 127.2, 127.1 (2C), 127.0 (2C), 124.7, 117.7 (1C, t, J = 24.0 Hz), 4.4, 0.9. 
MS (EI) m/z (rel. intensity): 207 (100), 192 (41), 166 (13), 152 (12), 129 (21), 102 (4), 91 
(15). HRMS (EI): calcd for C16H13D: 207.115829, found 207.115890. 
1-Benzyloxy-3-cyclopropylidenemethyl-benzene (5). Prepared analogously as a white solid 
(156 mg, 66%). m.p. 72-74°C. IR (KBr): 3066, 3033, 2966, 2939, 2886, 
1751, 1595, 1585, 1495, 1446, 1419, 1411, 1388, 1253, 1177, 1016, 
993, 936, 1862, 808, 744, 696 cm−1. 1H NMR (300 MHz, CDCl3): δ = 
7.52-7.32 (5H, m), 7.31-7.24 (1H, m), 7.23-7.19 (1H, m), 7.14 (1H, d, J = 7.3 Hz), 6.87 (1H, 
dd, J = 8.0, 2.6 Hz), 6.74 (1H, quint, J = 1.8 Hz), 5.12 (2H, s), 1.46-1.37 (2H, m), 1.24-1.15 
(2H, m). 13C NMR (75 MHz, CDCl3): δ = 159.1, 139.8, 137.3, 129.5, 128.7 (2C), 128.0, 
127.6 (2C), 124.9, 119.9, 118.2, 113.4, 112.9, 70.1, 4.4, 0.7. MS (EI) m/z (rel. intensity): 236 
(7), 145 (24), 91 (100). HRMS (EI): calcd for C17H16O: 236.120112, found 236.120433. Anal. 
calcd for C17H16O: C 86.41, H 6.82; found C 86.31, H 6.85. 
4-Cyclopropylidenemethyl-benzoic acid methyl ester (7). Prepared analogously as a white 
solid (113 mg, 60%). m.p. 53-55 °C. IR (KBr): 3077, 3037, 2977, 
2951, 2844, 1720, 1606, 1436, 1278, 1109, 866, 759, 697 cm−1. 1H 
NMR (300 MHz, CDCl3): δ = 8.00 (2H, d, J = 8.4 Hz), 7.58 (2H, d, J 
= 8.4 Hz), 6.81 (1H, quint, J = 2.0 Hz), 3.92 (3H, s), 1.52-1.44 (2H, m), 1.27-1.18 (2H, m). 
13C NMR (75 MHz, CDCl3): δ = 167.2, 143.0, 130.2 (2C), 128.3, 126.6 (2C), 117.9, 52.2, 4.7, 
0.9. MS (EI) m/z (rel. intensity): 188 (9), 157 (4), 129 (100). HRMS (EI): calcd for C12H12O2: 
188.083732, found 188.083656. Anal. calcd for C12H12O2: C 76.57, H 6.43; found C 76.62, H 
6.24. 
1-Bromo-2-cyclopropylidenemethyl-4,5-dimethoxy-benzene (9). Prepared analogously as a 
white solid (319 mg, 59%). m.p. 102-105 °C. IR (KBr): 2960, 2935, 
2908, 2835, 1778, 1597, 1505, 1461 ,1450, 1381, 1257, 1208, 1163, 
1026, 857. 1H NMR (300 MHz, CDCl3): δ = 7.38 (1H, s), 7.05 (1H, qt, 
J = 2.0 Hz), 7.02 (1H, s), 3.89 (3H, s), 3.88 (3H, s), 1.45-1.39 (2H, m), 1.25-1.20 (2H, m). 13C 
NMR (75 MHz, CDCl3): δ = 148.5, 148.3, 129.8, 124.9, 116.7, 115.2, 113.5, 109.4, 56.1, 
55.8, 3.7, 0.7. MS (EI) m/z (rel. intensity): 270 (17), 268 (17), 239 (86), 237 (87), 189 (100), 
145 (30). HRMS (ESIpos): calcd for C12H13BrO2+Na 290.999126, found 290.998798. Anal. 
calcd for C12H13BrO2: C 77.75, H 7.46; found C 77.63, H 7.51. 
2-Cyclopropylidenemethyl-1,4-dimethoxy-benzene (11). Prepared analogously as a white 
solid (75 mg, 64%). m.p. 68-70 °C. IR (KBr): 3114, 3085, 3045, 3008, 
2961, 2934, 2836, 1721, 1636, 1586, 1500, 1645, 1453, 1417, 1180, 









d, J = 3.0 Hz), 7.12 (1H, quint, J = 2.0 Hz), 6.84 (1H, d, J = 8.9 Hz), 6.75 (1H, dd, J = 8.9, 3.1 
Hz), 3.83 (3H, s), 3.80 (3H, s), 1.45-1.38 (2H, m), 1.22-1.15 (2H, m). 13C NMR (75 MHz, 
CDCl3): δ = 153.9, 150.9, 128.2, 125.0, 112.6, 112.4 (2C), 112.2, 56.6, 55.8, 4.1, 0.9. MS (EI) 
m/z (rel. intensity): 190 (51), 175 (27), 159 (100). HRMS (EI): calcd for C12H14O2: 
190.099377, found 190.09950. Anal. calcd for C12H14O2: C 75.76, H 7.42; found C 75.60, H 
7.42. 
1-tert-Butyl-(4-cyclopropyliden-butoxy)-dimethyl-silane (13). Prepared analogously as a 
colorless oil (123 mg, 43%). IR (neat): 3052, 2980, 2955, 2929, 2895, 
2857, 1256, 1101, 837, 775 cm−1. 1H NMR (300 MHz, CDCl3): δ = 
5.77 (1H, tt, J = 6.7, 2.1 Hz), 3.64 (2H, t, J = 6.7 Hz), 2.23 (2H, q, J = 
7.1 Hz), 1.68 (2H, quint, J = 6.8 Hz), 1.04-1.01 (4H, m), 0.91 (9H, s), 0.06 (6H, s). 13C NMR 
(75 MHz, CDCl3): δ = 121.4, 118.0, 63.0, 32.7, 28.3, 26.1 (3C), 18.5, 2.2, 2.0, −5.1 (2C). MS 
(EI) m/z (rel. intensity): 226 (1), 169 (43), 139 (21), 75 (100). HRMS (ESIpos): calcd for 
C13H26OSi: 226.175297, found 226.175518. 
2-Allyloxy-1-cyclopropylidenemethyl-3-methoxy-benzene (17). Prepared analogously as a 
colorless oil (173 mg, 80%). IR (neat): 3077, 3046, 3007, 2975, 2936, 2836, 1769, 1743, 
1647, 1596, 1579, 1475, 1439, 1420, 1271, 1208, 1092, 989, 927, 812, 
746 cm−1. 1H NMR (400 MHz, CDCl3): δ = 7.42 (1H, dd, J = 7.9, 1.4 
Hz), 7.14 (1H, quint, J = 2.0 Hz), 7.03 (1H, t, J = 8.0 Hz), 6.79 (1H, dd, 
J = 8.2, 1.4 Hz), 6.14 (1H, ddt, J = 17.2, 10.4, 5.8 Hz), 5.40 (1H, dq, J 
= 17.1, 1.6 Hz), 5.24 (1H, dq, J = 10.4, 1.2 Hz), 4.51 (2H, dt, J = 5.8, 1.3 Hz), 3.87 (3H, s), 
1.44-1.38 (2H, m), 1.20-1.15 (2H, m). 13C NMR (100 MHz, CDCl3): δ = 153.2, 145.1, 134.5, 
132.6, 125.4, 123.9, 118.5, 117.4, 112.5, 110.6, 74.4, 55.9, 4.2, 0.7. MS (EI) m/z (rel. 
intensity): 216 (7), 175 (100), 159 (12), 147 (7), 132 (18), 115 (15), 103 (10), 91 (10), 77 (9). 
HRMS (ESIpos): calcd for C14H16NaO2: 239.104248, found 239.104492. Anal. calcd for 
C14H16O2: C 68.74, H 6.29; found C 68.52, H 6.36. 
4-Cyclopropylidenemethyl-1,2-dimethoxy-benzene (22). Prepared analogously as a white 
solid (73 mg, 62%). m.p. 78-81 °C. IR (KBr): 3084, 3044, 3008, 2963, 
2925, 2840, 1781, 1600, 1585, 1516, 1471, 1455, 1419, 1229, 1158, 
1141, 1027, 858, 827, 787, 776 cm−1. 1H NMR (300 MHz, CDCl3): δ = 
7.16 (1H, d, J = 1.8 Hz), 7.05 (1H, dd, J = 8.3, 1.9 Hz), 6.85 (1H, d, J = 8.3 Hz), 6.69 (1H, 
quint, J = 2.0 Hz), 3.92 (3H, s), 3.90 (3H, s), 1.45-1.37 (2H, m), 1.21-1.14 (2H, m). 13C NMR 
(75 MHz, CDCl3): δ = 149.1, 148.2, 131.7, 122.2, 119.5, 118.0, 111.3, 109.4, 56.1, 55.9, 4.1, 
0.7. MS (EI) m/z (rel. intensity): 190 (31), 175 (14), 159 (100). HRMS (EI): calcd for 
C12H14O2: 190.099383, found 190.099238. Anal. calcd for C12H14O2: C 75.76, H 7.42; found 








1-Benzyloxy-4-cyclopropylidenemethyl-benzene (25). Prepared analogously as a white 
solid (145 mg, 56%). m.p. 72-74 °C. IR (KBr): 3060, 3037, 2968, 2942, 
2922, 2865, 1764, 1606, 1573, 1510, 1452, 1414, 1381, 1249, 1012, 
837, 741, 696 cm−1. 1H NMR (300 MHz, CDCl3): δ = 7.51-7.43 (3H, 
m), 7.42-7.38 (2H, m), 7.37-7.33 (1H, m), 6.96 (2H, d, J = 9.0 Hz), 6.70 (1H, quint, J = 2.0 
Hz), 5.09 (2H, s), 1.42-1.36 (2H, m), 1.19-1.14 (2H, m). 13C NMR (75 MHz, CDCl3): δ = 
157.8, 137.2, 131.6, 128.7 (2C), 128.1, 127.8 (2C), 127.6 (2C), 122.0, 117.6, 115.0 (2C), 
70.1, 4.1, 0.6. MS (EI) m/z (rel. intensity): 236 (6), 145 (52), 91 (100). HRMS (EI): calcd for 
C17H16O: 236.120118, found 236.120187. Anal. calcd for C17H16O: C 86.41, H 6.82; found C 
86.35, H 6.84. 
 (3-Cyclopropylidene-propyl)-benzene (15). t-BuOK (750 mg, 6.6 mmol) was added in 
portions within 15 minutes to a stirred suspension of 3-bromopropyl 
triphenylphosphonium bromide (1.56 g, 3.3 mmol) in THF (20 mL). 
The orange mixture was then stirred at 70°C for 2h, before 3-phenyl-
propionaldehyde (0.4 mL, 3 mmol) was added and reflux was continued for 2h. The reaction 
was quenched at room temperature with water, the aqueous layer was extracted twice with 
hexanes, and the combined organic layers were washed with brine and were dried over 
Na2SO4. Evaporation of the solvent followed by flash chromatography (pentanes) of the 
residue gave the title compound as a colorless oil (274 mg, 58%). IR (neat): 3027, 2978, 2924, 
2853, 1603, 1495, 1453, 1410, 743, 695 cm−1. 1H NMR (300 MHz, CDCl3): δ = 7.39-7.15 
(5H, m), 5.81 (1H, tt, J = 6.7, 2.1 Hz), 2.78 (2H, dd, J = 8.4, 7.2 Hz), 2.51 (2H, q, J = 7.5 Hz), 
1.07-0.93 (4H, m). 13C NMR (75 MHz, CDCl3): δ = 142.4, 128.6 (2C), 128.4 (2C), 125.8, 
122.1, 117.5, 35.9, 33.8, 2.3, 2.0. MS (EI) m/z (rel. intensity): 158 (2), 143 (22), 130 (28), 91 
(100). HRMS (EI): calcd for C12H14: 158.109548, found 158.109365. 
 
PtCl2 Catalyzed Rearrangement Reactions 
 
Representative Procedure: 4-Cyclobuten-1-yl-biphenyl (4). PtCl2 (1 mg, 0.0038 mmol) 
was added to a solution of 4-cyclopropylidenemethyl-biphenyl 3 (90 mg, 
0.437 mmol) in toluene (4.3 mL). CO was bubbled into the solution via a 
needle for ca. 30 seconds and the resulting mixture was then stirred at 80 
°C under CO atmosphere (1 atm). For work up, the mixture was filtered 
under Argon through a short pad of silica and the filtrate was evaporated to give product 4 as 
a white, air sensitive solid (69 mg, 77%). IR (KBr): 3054, 3030, 2949, 2915, 1867, 2834, 
1672, 1596, 1580, 1485, 1448, 1407, 840, 745, 689 cm−1. 1H NMR (300 MHz, CD3CN): δ = 
7.68-7.60 (4H, m), 7.50-7.42 (4H, m), 7.40-7.33 (1H, m), 6.82-6.80 (1H, t, J = 1.4 Hz), 2.87-
2.83 (2H, m), 2.57-2.53 (2H, m). 13C NMR (75 MHz, CD3CN): δ = 147.1, 141.4, 140.9, 




(rel. intensity): 206 (100), 191 (38), 178 (37), 165 (16), 152 (15), 128 (17), 101 (8), 91 (15). 
HRMS (EI): calcd for C16H14: 206.109547, found 206.109387. 
All other cyclobutenes were prepared analogously. Their analytical and spectroscopic data are 
compiled below: 
1-Benzyloxy-3-cyclobuten-1-yl-benzene (6). White, air sensitive solid (27 mg, 90%). IR 
(neat): 3041, 2948, 2918, 2838, 1591, 1576, 1485, 1464, 1455, 1433, 
1383, 1324, 1286, 1241, 1220, 1205, 1183, 1160, 1012, 852, 803, 746, 
696 cm−1. 1H NMR (300 MHz, CD3CN): δ = 7.49-7.32 (5H, m), 7.25 (1H, 
t, J = 7.8 Hz), 7.01-6.95 (2H, m), 6.92-6.86 (1H, m), 6.33 (1H, t, J = 1.4 
Hz), 5.11 (2H, s), 2.82-2.77 (2H, m), 2.55-2.48 (2H, m). 13C NMR (75 MHz, CD3CN): δ = 
160.0, 147.4, 138.5, 137.5, 130.5, 129.5 (2C), 128.9, 128.8, 128.7 (2C), 117.8, 115.3, 111.5, 
70.6, 29.5, 26.8. MS (EI) m/z (rel. intensity): 236 (16), 145 (3), 91 (100). HRMS (EI): calcd 
for C17H16O: 236.120119, found 236.120340. 
4-Cyclobuten-1-yl-benzoic acid methyl ester (8). White, air sensitive solid (25 mg, 80%). 
IR (neat): 2946, 2910, 2831, 1717, 1601 ,1567, 1433, 1410, 1276, 1108, 1027, 735 cm−1. 1H 
NMR (300 MHz, CD3CN): δ = 7.96 (2H, d, J = 8.4 Hz), 7.47 (2H, d, J 
= 7.7 Hz), 6.51 (1H, t, J = 1.4 Hz), 3.86 (3H, s), 2.88-2.83 (2H, m), 
2.58-2.53 (2H, m). 13C NMR (75 MHz, CD3CN): δ = 167.5, 146.6, 
140.0, 131.9, 130.5 (2C), 130.0, 125.1 (2C), 52.6, 29.4, 27.2. MS (EI) m/z (rel. intensity): 188 
(34), 157 (17), 129 (100), 59 (7). HRMS (EI): calcd for C12H12O2: 188.083730, found 
188.083494. 
1-Bromo-2-cyclobuten-1-yl-4,5-dimethoxy-benzene (10). White, air sensitive solid (18 mg, 
61%). IR (KBr): 3084, 3001, 2919, 2834, 1690, 1593, 1565, 1508, 1458, 
1432, 1338, 1259, 1211, 1170, 1027, 852, 785 cm−1. 1H NMR (300 MHz, 
CD2Cl2): δ = 6.99 (1H, s), 6.77 (1H, s), 6.56 (1H, s), 3.80 (6H, s), 2.92-
2.89 (2H, m), 2.51-2.46 (2H, m). 13C NMR (75 MHz, CD2Cl2): δ = 149.6, 
149.1, 145.1, 132.5, 127.6, 117.3, 112.2, 111.3, 56.8, 56.7, 31.8, 27.0. MS (EI) m/z (rel. 
intensity): 270 (37), 268 (38), 242 (10), 240 (8), 189 (100), 158 (58). HRMS (EI): calcd for 
C12H13BrO2: 268.009907, found 268.010036. 
2-Cyclobuten-1-yl-1,4-dimethoxy-benzene (12). Pale yellow, air sensitive solid (50 mg, 
50%). IR (KBr): 3001, 2956, 2911, 2832, 1613, 1586, 1497, 1464, 1452, 1442, 1397, 1315, 
1279, 1215, 1044, 854, 821, 814, 766, 739 cm−1. 1H NMR (300 MHz, 
CD3CN): δ = 6.88 (1H, d, J = 8.8 Hz), 6.79 (1H, dd, J = 8.8, 2.9 Hz), 
6.74 (1H, d, J = 3.3 Hz), 6.34 (1H, t, J = 1.3 Hz), 3.80 (3H, s), 3.74 (3H, 
s), 2.85-2.81 (2H, m), 2.56-2.51 (2H, m). 13C NMR (75 MHz, CD3CN): δ = 154.4, 153.6, 
143.9, 133.4, 125.3, 114.0, 113.2, 112.8, 56.2 (2C), 30.6, 27.8. MS (EI) m/z (rel. intensity): 










1-tert-Butyl-(4-cyclobuten-1-yl)-dimethyl-silane (14). Colorless, air sensitive oil (10 mg, 
93%). IR (neat): 2928, 2857, 1631, 1472, 1254, 1099, 832, 773 cm−1. 1H 
NMR (300 MHz, CDCl3): δ = 5.69-5.67 (1H, m), 3.64 (2H, t, J = 6.6 
Hz), 2.45-2.41 (2H, m), 2.36-2.32 (2H, m), 2.09-2.00 (2H, m), 1.66 (2H, 
quint, J = 6.7 Hz), 0.91 (9H, s), 0.06 (6H, s). 13C NMR (75 MHz, CDCl3): δ = 150.4, 126.9, 
63.0, 31.3, 30.1, 27.5, 26.6, 26.1 (3C), 18.5, −5.1 (2C). MS (EI) m/z (rel. intensity): 169 (47), 
141 (28), 75 (100). HRMS (CI): calcd for C13H17OSi: 227.183121, found 227.183220. 
 (3-Cyclobutenyl-propyl)-benzene (16). Colorless, air sensitive oil (30 mg, 95%). IR (neat): 
3028, 2919, 2841, 1629, 1604, 1496, 1453, 1410, 853, 747, 696 cm−1. 1H 
NMR (300 MHz, CDCl3): δ = 7.32-7.27 (2H, m), 7.23-7.17 (3H, m), 
5.71(1H, s), 2.79 (2H, dd, J = 8.2, 7.2 Hz), 2.46-2.43 (2H, m), 2.38-2.30 
(4H, m). 13C NMR (75 MHz, CDCl3): δ = 150.0, 142.3, 128.4 (4C), 127.4, 
125.9, 33.3, 33.0, 31.4, 26.7. MS (EI) m/z (rel. intensity): 158 (2), 143 (10), 130 (29), 91 
(100). HRMS (EI): calcd for C12H14: 158.109551, found 158.109352. 
Compound 23. PtCl2 (2 mg, 0.0075 mmol) was added to a solution of compound 22 (30 mg, 
0.158 mmol) in toluene (0.1 M) and the resulting mixture was 
stirred at 80°C under CO atmosphere for 4h. Purification of the 
crude mixture by flash chromatography (hexanes, then 
hexanes/EtOAc, 4/1) gave a first fraction of pure compound 23 (10 
mg) and second fraction of a mixture of 23 and its regioisomer 24 
(16 mg), both as colorless oils (combined yield 87%). IR (neat): 
2931, 1831, 1603, 1587, 1513, 1498, 1642, 1334, 1245, 1173, 1139, 1109, 1027, 849, 759 
cm−1. 1H NMR (600 MHz, CDCl3): δ = 6.94 (1H, s), 6.78 (1H, d, J = 8.3 Hz), 6.72 (1H, dd, J 
= 8.2, 2.1 Hz), 6.56 (1H, d, J = 2.1 Hz), 6.44 (1H, s), 3.93 (3H, s), 3.82 (3H, s), 3.76 (3H, s), 
3.74 (3H, s), 3.10 (1H, t, J = 8.1 Hz), 2.69 (1H, dt, J = 11.1, 9.7 Hz), 2.39-2.33 (1H, m), 2.26-
2.18 (4H, m), 2.08-1.94 (3H, m), 1.62-1.55 (1H, m). 13C NMR (150 MHz, CDCl3): δ = 149.2, 
149.0, 148.8, 147.0, 142.2, 141.0, 140.8, 117.6, 111.0, 109.6, 106.9, 105.8, 57.5, 57.3, 56.1, 
56.0, 55.9, 55.7, 53.4, 38.1, 29.6, 28.5, 19.5, 16.0. MS (EI) m/z (rel. intensity): 380 (42), 352 
(74), 324 (100). HRMS (ESIpos): calcd for C24H28O4+Na: 403.187979, found 403.188368. 
Regioisomer 24: (resolved signals) 1H NMR (400 MHz, CDCl3): δ = 7.00-6.95 (2H, m), 6.60 
(1H, d, J = 2.0 Hz), 3.83 (3H, s), 3.82 (3H, s), 3.80 (3H, s), 3.68 (3H, s), 2.66-2.56 (4H, m), 
2.55-2.48 (2H, m), 2.47-2.41 (2H, m). 13C NMR (100 MHz, CDCl3): δ = 148.9, 147.9, 147.2, 
145.9, 117.9, 110.6, 110.0, 109.9, 55.8, 55.6, 33.8, 26.6, 26.3, 25.4, 16.7. 
Compound 21. This compound was obtained analogously from 
substrate 11 as a white solid (16 mg, 53%). m.p. 160-163°C. IR 
(neat): 2942, 2831, 1587, 1487, 1463, 1436, 1416, 1281, 1253, 
1221, 1204, 1178, 1081, 1057, 1032, 874, 796, 725 cm−1. 1H NMR 











8.6 Hz), 6.66 (1H, d, J = 8.8 Hz), 6.63 (1H, dd, J = 8.8, 2.9 Hz), 6.57 (1H, d, J = 8.6 Hz), 3.86 
(3H, s), 3.72 (3H, s), 3.51 (3H, s), 3.47 (3H, s), 3.21 (1H, dd, J = 9.1, 7.5 Hz), 2.86 (1H, dt, J 
= 11.2, 9.9 Hz), 2.83-2.77 (1H, m), 2.62-2.55 (1H, m ), 2.21-2.09 (4H, m), 2.05 (1H, dddd, J 
= 11.9, 10.1, 9.1, 3.1), 1.85-1.77 (1H, m), 1.63 (1H, ddt, J = 11.9, 9.5, 7.5 Hz). 13C NMR (150 
MHz, CDCl3): δ = 152.9, 152.1, 151.9, 150.8, 139.9, 137.8, 135.5, 116.3, 111.8, 111.0, 110.2, 
110.1, 57.6, 55.9, 55.8, 55.7, 55.6, 55.5, 53.8, 35.4, 28.4, 27.2, 20.2, 15.3. MS (EI) m/z (rel. 
intensity): 380 (30), 352 (36), 324 (100). HRMS (ESIpos): calcd for C24H28O4+Na: 
403.187981, found 403.187676. 
Compound 26. Obtained analogously from substrate 25 as a white solid (13 mg, 43%). m.p. 
113-117°C. IR (neat): 3033, 2937, 2915, 2899, 2830, 1605, 1571, 
1506, 1467, 1454, 1380, 1287, 1235, 1173, 1013, 835, 811, 745, 698 
cm−1. 1H NMR (400 MHz, CDCl3): δ = 7.49-7.31 (10H, m), 7.09 
(2H, d, J = 8.8 Hz), 6.97 (2H, d, J = 8.3 Hz), 6.87 (2H, d, J = 8.8 
Hz), 5.07 (2H, s), 5.05 (2H, s), 2.68-2.63 (2H, m), 2.61-2.52 (4H, 
m), 2.51-2.42 (2H, m), 1.99-1.90 (2H, m). 13C NMR (100 MHz, 
CDCl3): δ = 157.2, 156.6, 145.3, 139.4, 136.9, 136.7, 136.3, 128.7, 128.2 (4C), 127.6, 127.58, 
127.5 (2C), 127.2 (2C), 127.1 (2C), 126.8 (2C), 114.3 (2C), 114.0 (2C), 69.7, 69.6, 47.3, 33.6 
(2C), 25.9, 25.1, 16.3. MS (EI) m/z (rel. intensity): 472 (8), 444 (4), 381 (21), 91 (100). 
HRMS (EI): calcd for C34H32O2: 472.240592, found 472.240233. 
4-But-3-enyl-8-methoxy-2H-chromene (19). PtCl2 (3.5 mg, 0.0132 mmol) was added to a 
solution of substrate 17 (33 mg, 0.139 mmol) in toluene (1.4 mL). 
The solution was stirred for 4.5 h at 80°C before it was transferred 
at room temperature into a flask containing a solution of the 
Grubbs catalyst Cl2(PCy3)2Ru=CHPh (5.7 mg, 0.00695 mmol) in 
CH2Cl2 (30 mL). The resulting mixture was refluxed for 30 min, 
the reaction was quenched with a few drops of ethyl vinyl ether, the solvent was evaporated, 
and the residue was purified by flash chromatography (hexanes/EtOAc, 20/1) to give 
chromene 19 as a yellow oil (21 mg, 64%). IR (neat): 3075, 2997, 2934, 2836, 1641, 1603, 
1576, 1477, 1440, 1270, 1220, 1199, 1176, 1152, 1091, 1050, 1007, 913 cm−1. 1H NMR (300 
MHz, CDCl3): δ = 6.95-6.79 (3H, m), 5.88 (1H, ddt, J = 17.0, 10.2, 6.5 Hz), 5.65-5.60 (1H, 
m), 5.07 (1H, dq, J = 17.0, 1.7 Hz), 5.01 (1H, dq, J = 10.1, 1.0 Hz), 4.83-4.79 (2H, m), 3.88 
(3H, s), 2.52-2.44 (2H, m), 2.35-2.26 (2H, m). 13C NMR (75 MHz, CDCl3): δ = 148.2, 143.5, 
138.1, 133.9, 124.4, 120.7, 117.9, 115.7, 115.1, 111.8, 65.7, 56.2, 32.2, 31.1. MS (EI) m/z 
(rel. intensity): 216 (100), 201 (19), 175 (30). HRMS (EI) : calcd for C14H16O2: 216.115032, 





























































































Figure S-1. Overview over the spectral data recorded for compound 23 (DMX 600 
spectrometer, CDCl3). 1H NMR shifts are given in red, 13C NMR shifts are shown in blue. 
The signal assignments are unambiguous, based upon 1D and 2D spectra recorded using the 
following pulse sequences from the Bruker standard pulse program library: DEPT; COSY 
(cosygs and cosydqtp); HSQC (invietgssi) optimized for 1J(C,H) = 145 Hz; HMBC 
(inv4gslplrnd) for correlations via nJ(C,H); HSQC-TOCSY (invietgsml) using an MLEV17 
mixing time of 120 ms. 
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Figure S-4. Overview over the spectral data recorded for compound 21 (DMX 600 
spectrometer, CDCl3). 1H NMR shifts are given in red, 13C NMR shifts are shown in blue. 
The signal assignments are unambiguous, based upon 1D and 2D spectra recorded using the 
following pulse sequences from the Bruker standard pulse program library: DEPT; COSY 
(cosygs and cosydqtp); HSQC (invietgssi) optimized for 1J(C,H) = 145 Hz; HMBC 
(inv4gslplrnd) for correlations via nJ(C,H); HSQC-TOCSY (invietgsml) using an MLEV17 
mixing time of 120 ms. 
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